Evidence map›Paper›PMID 41820938›Full record

ArticleBMC pulmonary medicine2026

Associated factors and predictive nomogram of long COVID: a cross-sectional study in China.

Zhijin Zhang, Yi Xue, Leyi Gao, Lujia Guan, Haifan Zhang, Haomiao Ma, Xuyan Li, Jieqiong Li, Huqin Yang, Zhaohui Tong

Abstract read
In one paragraph

Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zhijin ZhangDepartment of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, No. 8, Gong Ti South Road, Chao yang District, Beijing, 100020, China.
Yi XueDepartment of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, No. 8, Gong Ti South Road, Chao yang District, Beijing, 100020, China.
Leyi GaoDepartment of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, No. 8, Gong Ti South Road, Chao yang District, Beijing, 100020, China.
Lujia GuanDepartment of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, No. 8, Gong Ti South Road, Chao yang District, Beijing, 100020, China.
Haifan ZhangDepartment of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, No. 8, Gong Ti South Road, Chao yang District, Beijing, 100020, China.
Haomiao MaDepartment of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, No. 8, Gong Ti South Road, Chao yang District, Beijing, 100020, China.
Xuyan LiDepartment of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, No. 8, Gong Ti South Road, Chao yang District, Beijing, 100020, China.
Jieqiong LiDepartment of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, No. 8, Gong Ti South Road, Chao yang District, Beijing, 100020, China.
Huqin YangDepartment of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, No. 8, Gong Ti South Road, Chao yang District, Beijing, 100020, China. m15210516208@163.com.
Zhaohui TongDepartment of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, No. 8, Gong Ti South Road, Chao yang District, Beijing, 100020, China. tongzhaohuicy@sina.com.

Funding

Beijing Research Center for Respiratory Infectious Diseases Projec BJRID2024-008Beijing Scholars Program 062Ministry of Science and Technology of the People's Republic of China 2023YFC0872500
6 · The paper itself

Abstract

backgroundLong COVID (coronavirus disease) poses a substantial challenge to individual and global public health. In the context of China’s Omicron wave, key aspects such as its long-impact on non-hospitalized adults, the role of reinfection and other pathogenic infections during recovery require updated evidence. Therefore, the aim of this study is to delineate factors associated with long COVID and create a robust predictive model for primary-care to identify individuals at high risk of long COVID, utilizing data collected during the Omicron wave.

methodsThis study employed an online survey to assess SARS-CoV-2 infection status and track long COVID symptoms 9 to 15 months post-initial infection in 2099 participants. Associated factors of long COVID were identified through univariable and multivariable logistic regression analyses. The long COVID risk prediction model was visualized using a nomogram, and its performance was evaluated using the area under the curve (AUC) and a calibration curve.

resultsAn analysis of 1,408 valid responses revealed that 35.9% of participants reported persistent long COVID symptoms 9 to 15 months after their initial SARS-CoV-2 infection. During the rehabilitation period, SARS-CoV-2 re-infection and other respiratory infections were reported in 32.4% and 34.3% of cases, respectively. The most prevalent long COVID symptoms were as follows: fatigue (16.2%), cough (9.0%), decreased activity tolerance (7.3%), shortness of breath (6.0%), expectoration (5.8%), and forgetfulness (5.7%). Multivariable analysis identified the factors independently associated with long COVID: female gender, absence of comorbidities, frequency of SARS-CoV-2 infections, history of other respiratory infections, and the presence of seven acute symptoms. Using logistic regression analysis, we developed a nomogram for long COVID prediction, which achieved an AUC of 0.731. Additional subgroup analysis revealed that participants with either SARS-CoV-2 reinfection or other pathogenic respiratory infections were more likely to report both a higher number of long COVID symptoms and increased symptom severity.

conclusionsIn summary, to mitigate the risk of long COVID, it is critical to prevent SARS-CoV-2 reinfection and other respiratory infections during the post-infection period. We developed a user-friendly nomogram model with satisfactory predictive performance to evaluate the risk of long COVID among COVID-19 patients.

Indexed as

COVID-19NomogramsAdultAgedChinaCross-Sectional StudiesFemaleHumansLogistic ModelsMaleMiddle AgedPost-Acute COVID-19 SyndromeRisk FactorsSARS-CoV-2Long COVIDOmicronPrediction modelSARS-CoV-2

Identifiers

PMID41820938
PMCPMC13094175

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.